Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0J3CJ
|
||||
| Former ID |
DNC010395
|
||||
| Drug Name |
2-fluorophenyl 4-(octyloxy)phenylcarbamate
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [530604] | ||
| Formula |
C21H26FNO3
|
||||
| Canonical SMILES |
CCCCCCCCOC1=CC=C(C=C1)NC(=O)OC2=CC=CC=C2F
|
||||
| InChI |
1S/C21H26FNO3/c1-2-3-4-5-6-9-16-25-18-14-12-17(13-15-18)23-21(24)26-20-11-8-7-10-19(20)22/h7-8,10-15H,2-6,9,16H2,1H3,(H,23,24)
|
||||
| InChIKey |
PHBVHSXINCCZDW-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Fatty-acid amide hydrolase | Target Info | Inhibitor | [530604] | |
| BioCyc Pathway | Anandamide degradation | ||||
| KEGG Pathway | Retrograde endocannabinoid signaling | ||||
| PANTHER Pathway | Anandamide degradation | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.